Keratinocyte desmosome and stratum corneum intercellular matrix (null)

The keratinocyte desmosome is a specialized, multi-protein cell–cell junction that secures adjacent epidermal cells (keratinocytes) together, providing mechanical strength and resilience, particularly in the skin and heart[1][3][5][7]. Desmosomes consist of cadherins (desmogleins and desmocollins), armadillo family proteins (plakoglobin, plakophilins), and the cytolinker desmoplakin, anchoring the cell adhesion site to intermediate filaments[1][3][5][7]. In the upper layers of the epidermis, these mature into corneodesmosomes, which contribute to the physical cohesion of the outermost stratum corneum until their degradation allows for normal skin shedding (desquamation)[2]. The stratum corneum intercellular matrix is the extracellular domain within the outermost epidermal layer, filled with highly organized lipids (ceramides, cholesterol, free fatty acids) and barrier proteins surrounding corneocytes[2][4][6]. This matrix forms the principal skin permeability barrier, protecting against water loss, chemical exposure, and microbial invasion, and is dynamically remodeled during the process of cornification[4][6]. Dysfunction of either desmosomes or the stratum corneum matrix is central to many dermatological diseases affecting skin barrier integrity, hydration, and susceptibility to infection[2][4][5]. As a target, these complexes have been indirectly modulated using moisturizers and barrier repair formulations, and are implicated in genetic, autoimmune, and inflammatory skin diseases, but are not conventionally "drug targets" as with a single protein or receptor. Summary: The query does not refer to a single, canonical molecular target but rather to two essential, multi-component structural systems integral to epidermal barrier function and disease[1][2][3][4][5][6][7]. Neither qualifies as a standard therapeutic target, but both are vital in dermatology and research.

Other names

DesmosomeEpidermal desmosomeCorneodesmosome (in the stratum corneum)Stratum corneum extracellular matrixSC intercellular lipid matrix

Restoration of lipid matrix (barrier repair agents) Modulation of inflammation (corticosteroids, immunomodulators) Reduction of pathogenic autoantibody-mediated desmosome disruption (pemphigus treatment)